• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个体化导航微秒脉冲激光治疗急性中心性浆液性脉络膜视网膜病变的临床评估。

Clinical Evaluation of Individualized and Navigated Microsecond Pulsing Laser for Acute Central Serous Chorioretinopathy.

出版信息

Ophthalmic Surg Lasers Imaging Retina. 2020 Sep 1;51(9):512-520. doi: 10.3928/23258160-20200831-06.

DOI:10.3928/23258160-20200831-06
PMID:32955591
Abstract

BACKGROUND AND OBJECTIVE

A computational model has predicted parameters for using a navigated microsecond pulsing laser system to treat central serous chorioretinopathy (CSC).

PATIENTS AND METHODS

A prospective, single-center, interventional case series was conducted for patients with acute CSC who were enrolled following screening and informed consent. Treatment involved laser pulse duration of 50 μs, 2.4% Duty Cycle, 100 μm spot size, and 10 ms pulse duration.

RESULTS

Average best-corrected visual acuity (decimal) of 12 patients improved from 0.86 ± 0.03 at baseline to 0.97 ± 0.01 at 3 months. Baseline central retinal thickness decreased from 452.58 μm ± 24.53 μm at baseline to 249.25 μm ± 2.92 μm at 3 months. Retinal sensitivity improved from 24.1 dB ± 1.09 dB at baseline to 28.98 dB ± 0.23 dB at 3 months. In all cases, subretinal fluid was resorbed.

CONCLUSION

The parameter sets derived from the computer model can be applied safely and effectively for CSC treatment using the navigated microsecond pulsing laser system. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:512-520.].

摘要

背景与目的

一个计算模型已经预测出使用导航微秒脉冲激光系统治疗中心性浆液性脉络膜视网膜病变(CSC)的参数。

患者与方法

一项前瞻性、单中心、干预性病例系列研究纳入了急性 CSC 患者,这些患者在经过筛选和知情同意后被纳入研究。治疗包括激光脉冲持续时间 50 μs、2.4%占空比、100 μm 光斑大小和 10 ms 脉冲持续时间。

结果

12 名患者的平均最佳矫正视力(十进制)从基线时的 0.86 ± 0.03 提高到 3 个月时的 0.97 ± 0.01。基线中央视网膜厚度从基线时的 452.58 μm ± 24.53 μm 降低到 3 个月时的 249.25 μm ± 2.92 μm。视网膜敏感度从基线时的 24.1 dB ± 1.09 dB 提高到 3 个月时的 28.98 dB ± 0.23 dB。在所有情况下,视网膜下液均被吸收。

结论

从计算机模型得出的参数集可以安全有效地应用于导航微秒脉冲激光系统治疗 CSC。[眼科手术激光成像视网膜。2020;51:512-520.]。

相似文献

1
Clinical Evaluation of Individualized and Navigated Microsecond Pulsing Laser for Acute Central Serous Chorioretinopathy.个体化导航微秒脉冲激光治疗急性中心性浆液性脉络膜视网膜病变的临床评估。
Ophthalmic Surg Lasers Imaging Retina. 2020 Sep 1;51(9):512-520. doi: 10.3928/23258160-20200831-06.
2
Clinical Application of Fluorescein Angiography-Free Navigated Focal Laser Photocoagulation in Central Serous Chorioretinopathy.无荧光素血管造影导航的局灶性激光光凝术在中心性浆液性脉络膜视网膜病变中的临床应用
Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1;50(4):e118-e124. doi: 10.3928/23258160-20190401-16.
3
Central serous chorioretinopathy treated with navigated retinal laser photocoagulation: visual acuity and retinal sensitivity.导航视网膜激光光凝治疗中心性浆液性脉络膜视网膜病变:视力与视网膜敏感度
Ophthalmic Surg Lasers Imaging Retina. 2015 Mar;46(3):349-54. doi: 10.3928/23258160-20150323-09.
4
Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者接受选择性视网膜治疗(SRT)后的视网膜敏感性
Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):243-254. doi: 10.1007/s00417-016-3441-8. Epub 2016 Aug 6.
5
Selective Retina Therapy in Acute and Chronic-Recurrent Central Serous Chorioretinopathy.急性和慢性复发性中心性浆液性脉络膜视网膜病变的选择性视网膜治疗
Ophthalmologica. 2015;234(4):177-88. doi: 10.1159/000439188. Epub 2015 Sep 15.
6
Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.韩国患者慢性中心性浆液性脉络膜视网膜病变的自动实时反馈控制剂量测定选择性视网膜治疗。
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1375-1383. doi: 10.1007/s00417-017-3672-3. Epub 2017 Apr 18.
7
Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.经阈下微脉冲激光治疗的慢性中心性浆液性脉络膜视网膜病变患者的功能和形态学转归
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2299-2306. doi: 10.1007/s00417-017-3783-x. Epub 2017 Aug 22.
8
Early Focal Laser Photocoagulation in Acute Central Serous Chorioretinopathy: A Prospective, Randomized Study.急性中心性浆液性脉络膜视网膜病变的早期局灶性激光光凝:一项前瞻性随机研究
Ophthalmic Surg Lasers Imaging Retina. 2017 Jul 1;48(7):564-571. doi: 10.3928/23258160-20170630-07.
9
COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.使用半剂量维替泊芬或半光通量激光进行光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的比较
Retina. 2017 Feb;37(2):325-333. doi: 10.1097/IAE.0000000000001138.
10
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变消退后的视力和视网膜形态损害
BMC Ophthalmol. 2019 Jul 25;19(1):160. doi: 10.1186/s12886-019-1171-5.

引用本文的文献

1
Influence of Retinal Microsecond Pulse Laser Treatment in Central Serous Chorioretinopathy: A Short-Term Optical Coherence Tomography Angiography Study.视网膜微秒脉冲激光治疗中心性浆液性脉络膜视网膜病变的影响:一项短期光学相干断层扫描血管造影研究
J Clin Med. 2021 May 29;10(11):2418. doi: 10.3390/jcm10112418.